Innova Health & Wellness - Bakersfield

Innova Health & Wellness operates in Bakersfield, California, under the medical direction of Jason Chiriano, DO, FACS, a board-certified osteopathic physician and Fellow of the American College of Surgeons. Dr. Chiriano brings surgical expertise and osteopathic principles to a practice focused on regenerative medicine, hormone optimization, and metabolic health. The clinic serves patients throughout Kern County with both in-person appointments at their Bakersfield location and telehealth consultations for California residents seeking access to peptide therapies and functional medicine protocols without geographic limitations.

The clinic's peptide therapy program centers on three primary agents: semaglutide and tirzepatide for metabolic dysfunction and weight management, and PT-141 (bremelanotide) for sexual health concerns including erectile dysfunction. Semaglutide, a GLP-1 receptor agonist, is prescribed as part of comprehensive weight loss protocols that include metabolic assessment, nutritional guidance, and ongoing monitoring. Tirzepatide, which activates both GLP-1 and GIP receptors, is offered for patients requiring dual incretin therapy for more resistant metabolic conditions. PT-141 is administered for erectile dysfunction and low libido through a mechanism distinct from vascular-focused treatments, acting on melanocortin receptors in the central nervous system. Each peptide protocol includes baseline laboratory evaluation, dose titration based on individual response, and regular follow-up to assess efficacy and manage potential side effects.

Dr. Chiriano's background as a Fellow of the American College of Surgeons informs his approach to regenerative medicine and pain management, bringing procedural precision to interventional treatments. His board certification and osteopathic training allow for integration of structural assessment with biochemical optimization. The clinic's hormone therapy services address testosterone deficiency, thyroid dysfunction, and other endocrine imbalances through bioidentical hormone replacement when clinically indicated. Pain management protocols combine regenerative injection techniques with peptide therapies designed to modulate inflammation and support tissue repair. This multidisciplinary approach allows patients to address interconnected issues—such as metabolic syndrome contributing to both weight gain and erectile dysfunction—within a single treatment framework.

Patients at Innova Health & Wellness begin with a comprehensive consultation that includes medical history review, symptom assessment, and discussion of treatment goals. For weight loss candidates, this initial visit typically involves body composition analysis, metabolic panel, and evaluation for contraindications to GLP-1 or GIP agonist therapy. Erectile dysfunction consultations include cardiovascular risk assessment and discussion of how PT-141 differs from PDE5 inhibitors in mechanism and administration. Hormone therapy patients undergo comprehensive hormone panels including total and free testosterone, estradiol, thyroid function, and other markers relevant to their presentation. The clinic provides clear protocols for peptide administration, including subcutaneous injection training for self-administered therapies, and establishes monitoring schedules based on the specific treatment plan.

Telehealth availability throughout California extends access to patients in rural areas of the Central Valley and beyond who may lack local providers offering peptide therapies or functional medicine approaches. Virtual consultations follow the same clinical rigor as in-person visits, with laboratory work coordinated through local facilities and prescriptions managed through partnered pharmacies experienced in compounding peptides. The Bakersfield office accommodates patients preferring face-to-face evaluation or requiring in-office procedures as part of their regenerative medicine or pain management protocols. Innova Health & Wellness maintains a clinical model focused on measurable outcomes, with treatment adjustments based on objective markers rather than symptom reporting alone, and emphasizes patient education regarding the mechanisms, realistic timelines, and evidence base for each therapeutic intervention offered.